These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 9332178)
1. Antimicrobial potentiality of a new beta-lactum antibiotic fosfomycin. Dastidar SG; Mazumdar A; Mookerjee M; Chakrabarty AN Indian J Exp Biol; 1997 Mar; 35(3):300-1. PubMed ID: 9332178 [TBL] [Abstract][Full Text] [Related]
2. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria. Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989 [TBL] [Abstract][Full Text] [Related]
3. The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. Schito GC; Naber KG; Botto H; Palou J; Mazzei T; Gualco L; Marchese A Int J Antimicrob Agents; 2009 Nov; 34(5):407-13. PubMed ID: 19505803 [TBL] [Abstract][Full Text] [Related]
4. [Fosfomycin. I. Antimicrobial action in vitro]. Carlone NA; Cuffini AM; Cattaneo O G Batteriol Virol Immunol; 1977; 70(1-6):100-7. PubMed ID: 614140 [TBL] [Abstract][Full Text] [Related]
5. Fosfomycin: use beyond urinary tract and gastrointestinal infections. Falagas ME; Giannopoulou KP; Kokolakis GN; Rafailidis PI Clin Infect Dis; 2008 Apr; 46(7):1069-77. PubMed ID: 18444827 [TBL] [Abstract][Full Text] [Related]
6. [Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005]. Yang QW; Xu YC; Chen MJ; Hu YJ; Ni YX; Sun JY; Yu YS; Kong HS; He L; Wu WY; Ye HF; Yang YM; Zhu LN; Guo SH; Ji P; Zhu ZH; Ren JK; Zhang LX; Sun ZY; Zhu XH; Tong MQ; Zhao WS; Mei YN; Liu Y; Zhang ZJ; Duan Q; Li D; Liu PP; Wang J; Han LX; Wang H; Xie XL Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2753-8. PubMed ID: 18167265 [TBL] [Abstract][Full Text] [Related]
7. Potency and spectrum of garenoxacin tested against an international collection of skin and soft tissue infection pathogens: report from the SENTRY antimicrobial surveillance program (1999-2004). Fritsche TR; Sader HS; Jones RN Diagn Microbiol Infect Dis; 2007 May; 58(1):19-26. PubMed ID: 17383139 [TBL] [Abstract][Full Text] [Related]
8. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004). Jones RN; Sader HS; Fritsche TR; Pottumarthy S Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of antimicrobial activity of beta-lactam antibiotics using Etest against clinical isolates from 60 medical centres in Japan. Ishii Y; Alba J; Kimura S; Shiroto K; Yamaguchi K Int J Antimicrob Agents; 2005 Apr; 25(4):296-301. PubMed ID: 15784308 [TBL] [Abstract][Full Text] [Related]
10. [Clinical experience with fosfomycin in urinary tract infections (author's transl)]. Peters HJ; Eicher R MMW Munch Med Wochenschr; 1981 May; 123(18):748-50. PubMed ID: 6785627 [TBL] [Abstract][Full Text] [Related]
11. Antimicrobial potentiality of a phenothiazine group of antipsychotic drug-prochlorperazine. Mazumder R; Chaudhuri SR; Mazumder A Indian J Exp Biol; 2002 Jul; 40(7):828-30. PubMed ID: 12597553 [TBL] [Abstract][Full Text] [Related]
12. Potency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000-2004). Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN Diagn Microbiol Infect Dis; 2005 Jul; 52(3):195-201. PubMed ID: 16105564 [TBL] [Abstract][Full Text] [Related]
13. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia. Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563 [TBL] [Abstract][Full Text] [Related]
14. Antimicrobial activity of fosfomycin in vitro. Forsgren A; Walder M J Antimicrob Chemother; 1983 May; 11(5):467-71. PubMed ID: 6874631 [TBL] [Abstract][Full Text] [Related]
15. In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients. Giacometti A; Cirioni O; Kamysz W; D'Amato G; Silvestri C; Licci A; Nadolski P; Riva A; Lukasiak J; Scalise G Int J Antimicrob Agents; 2005 Sep; 26(3):235-40. PubMed ID: 16122911 [TBL] [Abstract][Full Text] [Related]
16. Restoration of antibacterial activity of beta-lactams by epigallocatechin gallate against beta-lactamase-producing species depending on location of beta-lactamase. Zhao WH; Asano N; Hu ZQ; Shimamura T J Pharm Pharmacol; 2003 Jun; 55(6):735-40. PubMed ID: 12841932 [TBL] [Abstract][Full Text] [Related]
17. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in Antananarivo, Madagascar. Randrianirina F; Soares JL; Carod JF; Ratsima E; Thonnier V; Combe P; Grosjean P; Talarmin A J Antimicrob Chemother; 2007 Feb; 59(2):309-12. PubMed ID: 17138569 [TBL] [Abstract][Full Text] [Related]
18. Effects of subinhibitory concentrations of fosfomycin on bacteria. Lorian V; Atkinson B G Ital Chemioter; 1977; 23(2):65-74. PubMed ID: 342326 [No Abstract] [Full Text] [Related]
19. Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline. Garau J Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():198-202. PubMed ID: 18154548 [TBL] [Abstract][Full Text] [Related]
20. Impact of pH on activity of trimethoprim, fosfomycin, amikacin, colistin and ertapenem in human urine. Burian A; Erdogan Z; Jandrisits C; Zeitlinger M Pharmacology; 2012; 90(5-6):281-7. PubMed ID: 23037005 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]